drugset / Trial / NCT05657418
A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced Pancreatic Cancer
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this phase I clinical study was to evaluate the safety and tolerability of JS107 monotherapy and combination with Toripalimab in patients with Advanced pancreatic cancer.
Timeline
- Start
- 2022-03-29
- Primary completion
- 2025-01-04
- Completion
- 2025-01-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JS107 | Unknown | — | Intravenous |
| Background | Toripalimab | Monoclonal antibody | — | — |